Improving the quality of care for inflammatory bowel disease

Abstract

Great strides have been achieved in the development of quality-of-care measures and standards for inflammatory bowel disease (IBD) over the last decade. The central structural component of care in IBD revolves around the multidisciplinary team, which should be equipped with the necessary resources to operate and implement decisions. Process measures have been defined by interest groups and can be adapted into process tools for the delivery of care for various patient subgroups and clinical scenarios. The emerging treat-to-target approach to IBD management may be used to achieve optimal long-term and holistic patient-centred outcomes, such as survival, control of inflammation and disease progression, symptomatic remission, quality of life and complications. Other important quality-of-care outcome measures for IBD include disutility of care, healthcare utilization and other patient-reported outcomes such as nutritional status and impact of fistulae. The current challenge for healthcare providers and health systems is the integration of quality-of-care structures and processes into clinical practice, and the consistent delivery of updated evidence-based quality IBD care to various patient populations by individual health care providers. Finally, the awareness and appreciation for quality of care in IBD is increasing in Asia, and Asian healthcare institutions should be encouraged to take the lead in improving the quality of care in IBD.

Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005‐2013

“…There is growing international interest in quality improvement and benchmarking of IBD care within individual health care systems and between countries . The UK IBD Audit has served as a model for a recent national programme in Australia .…”

Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases

“…2,3 Thus, risk assessment for viral hepatitis is one of the important quality process indicators for the management of IBD patients. 4 In addition, several areas of Asia, including Korea, show in-pISSN 1598-9100 • eISSN 2288-1956 https://doi.The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD.…”

“…2,3 Thus, risk assessment for viral hepatitis is one of the important quality process indicators for the management of IBD patients. 4 In addition, several areas of Asia, including Korea, show in-pISSN 1598-9100 • eISSN 2288-1956 https://doi.…”

Subjective Needs and Thoughts for the Treatment of Patients with Inflammatory Bowel Disease: Applying Q Methodology

“…Awareness of the quality of care is increasing [1,2]. The increased incidence of in ammatory bowel disease (IBD), including chronic in ammatory gastrointestinal-impaired ulcerative colitis (UC) and…”

“…Several studies have reported on the quality of care in IBD patients [7][8][9][10]. To improve the quality of care of these patients, Donabedian's framework, which is composed of structure, process, and outcomes, can be used to set speci c and measurable goals [1,11]. Based on this framework, various quality indicators for IBD patients have been reported.…”